Bambao, Norlyn A.
HRN: 23-48-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2023
CEFUROXIME 1.5GM (VIAL)
10/02/2023
10/08/2023
IVT
1.5 Gms
On Call To OR Then Q 8 Hrs
TAHBSO
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes